nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezogabine—UGT1A1—Estradiol—osteoporosis	0.137	1	CbGbCtD
Ezogabine—Dyspepsia—Etidronic acid—osteoporosis	0.00219	0.00272	CcSEcCtD
Ezogabine—Discomfort—Alendronate—osteoporosis	0.00218	0.00271	CcSEcCtD
Ezogabine—Alopecia—Ethinyl Estradiol—osteoporosis	0.00217	0.00269	CcSEcCtD
Ezogabine—Mental disorder—Ethinyl Estradiol—osteoporosis	0.00215	0.00267	CcSEcCtD
Ezogabine—Anxiety—Ibandronate—osteoporosis	0.00214	0.00266	CcSEcCtD
Ezogabine—Infection—Estropipate—osteoporosis	0.00214	0.00265	CcSEcCtD
Ezogabine—Liver function test abnormal—Estradiol—osteoporosis	0.00214	0.00265	CcSEcCtD
Ezogabine—Malnutrition—Ethinyl Estradiol—osteoporosis	0.00214	0.00265	CcSEcCtD
Ezogabine—Constipation—Etidronic acid—osteoporosis	0.00213	0.00264	CcSEcCtD
Ezogabine—Discomfort—Ibandronate—osteoporosis	0.00213	0.00264	CcSEcCtD
Ezogabine—Eye disorder—Pamidronate—osteoporosis	0.00212	0.00264	CcSEcCtD
Ezogabine—Nervous system disorder—Estropipate—osteoporosis	0.00211	0.00262	CcSEcCtD
Ezogabine—Hepatobiliary disease—Conjugated Estrogens—osteoporosis	0.00211	0.00261	CcSEcCtD
Ezogabine—Infection—Alendronate—osteoporosis	0.0021	0.00261	CcSEcCtD
Ezogabine—Dry mouth—Ibandronate—osteoporosis	0.0021	0.00261	CcSEcCtD
Ezogabine—Anxiety—Calcitriol—osteoporosis	0.0021	0.0026	CcSEcCtD
Ezogabine—Mental disorder—Risedronate—osteoporosis	0.0021	0.0026	CcSEcCtD
Ezogabine—Malnutrition—Risedronate—osteoporosis	0.00208	0.00258	CcSEcCtD
Ezogabine—Discomfort—Calcitriol—osteoporosis	0.00208	0.00258	CcSEcCtD
Ezogabine—Infection—Raloxifene—osteoporosis	0.00207	0.00257	CcSEcCtD
Ezogabine—Dry mouth—Calcitriol—osteoporosis	0.00206	0.00256	CcSEcCtD
Ezogabine—Muscle spasms—Ethinyl Estradiol—osteoporosis	0.00205	0.00255	CcSEcCtD
Ezogabine—Urinary tract disorder—Zoledronate—osteoporosis	0.00205	0.00255	CcSEcCtD
Ezogabine—Shock—Raloxifene—osteoporosis	0.00205	0.00254	CcSEcCtD
Ezogabine—Infection—Ibandronate—osteoporosis	0.00205	0.00254	CcSEcCtD
Ezogabine—Feeling abnormal—Etidronic acid—osteoporosis	0.00205	0.00254	CcSEcCtD
Ezogabine—Oedema peripheral—Zoledronate—osteoporosis	0.00205	0.00254	CcSEcCtD
Ezogabine—Nervous system disorder—Raloxifene—osteoporosis	0.00204	0.00253	CcSEcCtD
Ezogabine—Thrombocytopenia—Raloxifene—osteoporosis	0.00204	0.00253	CcSEcCtD
Ezogabine—Urethral disorder—Zoledronate—osteoporosis	0.00204	0.00253	CcSEcCtD
Ezogabine—Shock—Ibandronate—osteoporosis	0.00203	0.00252	CcSEcCtD
Ezogabine—Nervous system disorder—Ibandronate—osteoporosis	0.00202	0.00251	CcSEcCtD
Ezogabine—Hyperhidrosis—Raloxifene—osteoporosis	0.00201	0.0025	CcSEcCtD
Ezogabine—Alopecia—Pamidronate—osteoporosis	0.00201	0.00249	CcSEcCtD
Ezogabine—Muscle spasms—Risedronate—osteoporosis	0.002	0.00248	CcSEcCtD
Ezogabine—Dysphagia—Estradiol—osteoporosis	0.002	0.00248	CcSEcCtD
Ezogabine—Influenza—Estradiol—osteoporosis	0.002	0.00248	CcSEcCtD
Ezogabine—Hyperhidrosis—Ibandronate—osteoporosis	0.00199	0.00247	CcSEcCtD
Ezogabine—Nausea—Ergocalciferol—osteoporosis	0.00199	0.00247	CcSEcCtD
Ezogabine—Ill-defined disorder—Ethinyl Estradiol—osteoporosis	0.00198	0.00246	CcSEcCtD
Ezogabine—Malnutrition—Pamidronate—osteoporosis	0.00198	0.00246	CcSEcCtD
Ezogabine—Oedema peripheral—Conjugated Estrogens—osteoporosis	0.00197	0.00244	CcSEcCtD
Ezogabine—Eye disorder—Zoledronate—osteoporosis	0.00194	0.00241	CcSEcCtD
Ezogabine—Paraesthesia—Estropipate—osteoporosis	0.00193	0.0024	CcSEcCtD
Ezogabine—Visual impairment—Conjugated Estrogens—osteoporosis	0.00193	0.00239	CcSEcCtD
Ezogabine—Malaise—Ethinyl Estradiol—osteoporosis	0.00193	0.00239	CcSEcCtD
Ezogabine—Somnolence—Estropipate—osteoporosis	0.00191	0.00237	CcSEcCtD
Ezogabine—Muscle spasms—Pamidronate—osteoporosis	0.0019	0.00236	CcSEcCtD
Ezogabine—Dyspepsia—Estropipate—osteoporosis	0.00189	0.00235	CcSEcCtD
Ezogabine—Vertigo—Risedronate—osteoporosis	0.00187	0.00232	CcSEcCtD
Ezogabine—Eye disorder—Conjugated Estrogens—osteoporosis	0.00187	0.00232	CcSEcCtD
Ezogabine—Syncope—Risedronate—osteoporosis	0.00187	0.00232	CcSEcCtD
Ezogabine—Dyspepsia—Alendronate—osteoporosis	0.00186	0.00231	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Estropipate—osteoporosis	0.00186	0.0023	CcSEcCtD
Ezogabine—Fatigue—Estropipate—osteoporosis	0.00185	0.0023	CcSEcCtD
Ezogabine—Paraesthesia—Ibandronate—osteoporosis	0.00185	0.0023	CcSEcCtD
Ezogabine—Constipation—Estropipate—osteoporosis	0.00184	0.00228	CcSEcCtD
Ezogabine—Ill-defined disorder—Pamidronate—osteoporosis	0.00184	0.00228	CcSEcCtD
Ezogabine—Alopecia—Zoledronate—osteoporosis	0.00184	0.00228	CcSEcCtD
Ezogabine—Dyspepsia—Raloxifene—osteoporosis	0.00183	0.00228	CcSEcCtD
Ezogabine—Loss of consciousness—Risedronate—osteoporosis	0.00183	0.00227	CcSEcCtD
Ezogabine—Weight increased—Estradiol—osteoporosis	0.00182	0.00226	CcSEcCtD
Ezogabine—Mental disorder—Zoledronate—osteoporosis	0.00182	0.00226	CcSEcCtD
Ezogabine—Dyspepsia—Ibandronate—osteoporosis	0.00181	0.00225	CcSEcCtD
Ezogabine—Anxiety—Ethinyl Estradiol—osteoporosis	0.00181	0.00225	CcSEcCtD
Ezogabine—Constipation—Alendronate—osteoporosis	0.00181	0.00225	CcSEcCtD
Ezogabine—Malnutrition—Zoledronate—osteoporosis	0.00181	0.00224	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Raloxifene—osteoporosis	0.0018	0.00223	CcSEcCtD
Ezogabine—Discomfort—Ethinyl Estradiol—osteoporosis	0.0018	0.00223	CcSEcCtD
Ezogabine—Somnolence—Calcitriol—osteoporosis	0.00179	0.00223	CcSEcCtD
Ezogabine—Malaise—Pamidronate—osteoporosis	0.00178	0.00222	CcSEcCtD
Ezogabine—Infestation NOS—Estradiol—osteoporosis	0.00178	0.00221	CcSEcCtD
Ezogabine—Infestation—Estradiol—osteoporosis	0.00178	0.00221	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Ibandronate—osteoporosis	0.00178	0.00221	CcSEcCtD
Ezogabine—Fatigue—Ibandronate—osteoporosis	0.00178	0.00221	CcSEcCtD
Ezogabine—Syncope—Pamidronate—osteoporosis	0.00177	0.0022	CcSEcCtD
Ezogabine—Leukopenia—Pamidronate—osteoporosis	0.00177	0.0022	CcSEcCtD
Ezogabine—Alopecia—Conjugated Estrogens—osteoporosis	0.00177	0.00219	CcSEcCtD
Ezogabine—Anxiety—Risedronate—osteoporosis	0.00177	0.00219	CcSEcCtD
Ezogabine—Constipation—Ibandronate—osteoporosis	0.00176	0.00219	CcSEcCtD
Ezogabine—Mental disorder—Conjugated Estrogens—osteoporosis	0.00175	0.00217	CcSEcCtD
Ezogabine—Feeling abnormal—Alendronate—osteoporosis	0.00175	0.00217	CcSEcCtD
Ezogabine—Malnutrition—Conjugated Estrogens—osteoporosis	0.00174	0.00216	CcSEcCtD
Ezogabine—Loss of consciousness—Pamidronate—osteoporosis	0.00174	0.00216	CcSEcCtD
Ezogabine—Muscle spasms—Zoledronate—osteoporosis	0.00174	0.00216	CcSEcCtD
Ezogabine—Dry mouth—Risedronate—osteoporosis	0.00173	0.00215	CcSEcCtD
Ezogabine—Infection—Ethinyl Estradiol—osteoporosis	0.00173	0.00215	CcSEcCtD
Ezogabine—Constipation—Calcitriol—osteoporosis	0.00173	0.00214	CcSEcCtD
Ezogabine—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.00171	0.00212	CcSEcCtD
Ezogabine—Vision blurred—Zoledronate—osteoporosis	0.0017	0.00211	CcSEcCtD
Ezogabine—Haematuria—Estradiol—osteoporosis	0.0017	0.00211	CcSEcCtD
Ezogabine—Feeling abnormal—Ibandronate—osteoporosis	0.0017	0.00211	CcSEcCtD
Ezogabine—Tremor—Zoledronate—osteoporosis	0.00169	0.0021	CcSEcCtD
Ezogabine—Infection—Risedronate—osteoporosis	0.00169	0.0021	CcSEcCtD
Ezogabine—Hepatobiliary disease—Estradiol—osteoporosis	0.00169	0.00209	CcSEcCtD
Ezogabine—Anxiety—Pamidronate—osteoporosis	0.00168	0.00208	CcSEcCtD
Ezogabine—Ill-defined disorder—Zoledronate—osteoporosis	0.00168	0.00208	CcSEcCtD
Ezogabine—Muscle spasms—Conjugated Estrogens—osteoporosis	0.00167	0.00208	CcSEcCtD
Ezogabine—Shock—Risedronate—osteoporosis	0.00167	0.00207	CcSEcCtD
Ezogabine—Nervous system disorder—Risedronate—osteoporosis	0.00167	0.00207	CcSEcCtD
Ezogabine—Discomfort—Pamidronate—osteoporosis	0.00166	0.00207	CcSEcCtD
Ezogabine—Vision blurred—Conjugated Estrogens—osteoporosis	0.00164	0.00204	CcSEcCtD
Ezogabine—Malaise—Zoledronate—osteoporosis	0.00163	0.00202	CcSEcCtD
Ezogabine—Confusional state—Pamidronate—osteoporosis	0.00163	0.00202	CcSEcCtD
Ezogabine—Vertigo—Zoledronate—osteoporosis	0.00162	0.00202	CcSEcCtD
Ezogabine—Syncope—Zoledronate—osteoporosis	0.00162	0.00201	CcSEcCtD
Ezogabine—Leukopenia—Zoledronate—osteoporosis	0.00162	0.00201	CcSEcCtD
Ezogabine—Infection—Pamidronate—osteoporosis	0.0016	0.00199	CcSEcCtD
Ezogabine—Shock—Pamidronate—osteoporosis	0.00159	0.00197	CcSEcCtD
Ezogabine—Loss of consciousness—Zoledronate—osteoporosis	0.00159	0.00197	CcSEcCtD
Ezogabine—Nervous system disorder—Pamidronate—osteoporosis	0.00158	0.00197	CcSEcCtD
Ezogabine—Thrombocytopenia—Pamidronate—osteoporosis	0.00158	0.00196	CcSEcCtD
Ezogabine—Urinary tract disorder—Estradiol—osteoporosis	0.00158	0.00196	CcSEcCtD
Ezogabine—Oedema peripheral—Estradiol—osteoporosis	0.00158	0.00196	CcSEcCtD
Ezogabine—Urethral disorder—Estradiol—osteoporosis	0.00157	0.00195	CcSEcCtD
Ezogabine—Rash—Etidronic acid—osteoporosis	0.00157	0.00194	CcSEcCtD
Ezogabine—Dermatitis—Etidronic acid—osteoporosis	0.00157	0.00194	CcSEcCtD
Ezogabine—Vertigo—Conjugated Estrogens—osteoporosis	0.00156	0.00194	CcSEcCtD
Ezogabine—Hyperhidrosis—Pamidronate—osteoporosis	0.00156	0.00194	CcSEcCtD
Ezogabine—Syncope—Conjugated Estrogens—osteoporosis	0.00156	0.00194	CcSEcCtD
Ezogabine—Asthenia—Estropipate—osteoporosis	0.00154	0.00191	CcSEcCtD
Ezogabine—Visual impairment—Estradiol—osteoporosis	0.00154	0.00191	CcSEcCtD
Ezogabine—Anxiety—Zoledronate—osteoporosis	0.00153	0.0019	CcSEcCtD
Ezogabine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.00153	0.0019	CcSEcCtD
Ezogabine—Paraesthesia—Risedronate—osteoporosis	0.00153	0.00189	CcSEcCtD
Ezogabine—Discomfort—Zoledronate—osteoporosis	0.00152	0.00189	CcSEcCtD
Ezogabine—Asthenia—Alendronate—osteoporosis	0.00152	0.00189	CcSEcCtD
Ezogabine—Dyspnoea—Risedronate—osteoporosis	0.00151	0.00188	CcSEcCtD
Ezogabine—Dry mouth—Zoledronate—osteoporosis	0.00151	0.00187	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.0015	0.00187	CcSEcCtD
Ezogabine—Fatigue—Ethinyl Estradiol—osteoporosis	0.0015	0.00186	CcSEcCtD
Ezogabine—Dyspepsia—Risedronate—osteoporosis	0.0015	0.00186	CcSEcCtD
Ezogabine—Eye disorder—Estradiol—osteoporosis	0.0015	0.00186	CcSEcCtD
Ezogabine—Constipation—Ethinyl Estradiol—osteoporosis	0.00149	0.00185	CcSEcCtD
Ezogabine—Confusional state—Zoledronate—osteoporosis	0.00149	0.00185	CcSEcCtD
Ezogabine—Asthenia—Ibandronate—osteoporosis	0.00148	0.00184	CcSEcCtD
Ezogabine—Anxiety—Conjugated Estrogens—osteoporosis	0.00148	0.00183	CcSEcCtD
Ezogabine—Nausea—Etidronic acid—osteoporosis	0.00148	0.00183	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Risedronate—osteoporosis	0.00147	0.00182	CcSEcCtD
Ezogabine—Infection—Zoledronate—osteoporosis	0.00147	0.00182	CcSEcCtD
Ezogabine—Fatigue—Risedronate—osteoporosis	0.00146	0.00182	CcSEcCtD
Ezogabine—Constipation—Risedronate—osteoporosis	0.00145	0.0018	CcSEcCtD
Ezogabine—Shock—Zoledronate—osteoporosis	0.00145	0.0018	CcSEcCtD
Ezogabine—Paraesthesia—Pamidronate—osteoporosis	0.00145	0.0018	CcSEcCtD
Ezogabine—Asthenia—Calcitriol—osteoporosis	0.00145	0.0018	CcSEcCtD
Ezogabine—Nervous system disorder—Zoledronate—osteoporosis	0.00145	0.0018	CcSEcCtD
Ezogabine—Thrombocytopenia—Zoledronate—osteoporosis	0.00144	0.00179	CcSEcCtD
Ezogabine—Dyspnoea—Pamidronate—osteoporosis	0.00144	0.00179	CcSEcCtD
Ezogabine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00144	0.00178	CcSEcCtD
Ezogabine—Somnolence—Pamidronate—osteoporosis	0.00144	0.00178	CcSEcCtD
Ezogabine—Hyperhidrosis—Zoledronate—osteoporosis	0.00143	0.00177	CcSEcCtD
Ezogabine—Dyspepsia—Pamidronate—osteoporosis	0.00142	0.00176	CcSEcCtD
Ezogabine—Dizziness—Estropipate—osteoporosis	0.00142	0.00176	CcSEcCtD
Ezogabine—Alopecia—Estradiol—osteoporosis	0.00141	0.00176	CcSEcCtD
Ezogabine—Infection—Conjugated Estrogens—osteoporosis	0.00141	0.00175	CcSEcCtD
Ezogabine—Mental disorder—Estradiol—osteoporosis	0.0014	0.00174	CcSEcCtD
Ezogabine—Dizziness—Alendronate—osteoporosis	0.0014	0.00174	CcSEcCtD
Ezogabine—Shock—Conjugated Estrogens—osteoporosis	0.0014	0.00173	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00139	0.00173	CcSEcCtD
Ezogabine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00139	0.00173	CcSEcCtD
Ezogabine—Malnutrition—Estradiol—osteoporosis	0.00139	0.00173	CcSEcCtD
Ezogabine—Fatigue—Pamidronate—osteoporosis	0.00139	0.00173	CcSEcCtD
Ezogabine—Constipation—Pamidronate—osteoporosis	0.00138	0.00171	CcSEcCtD
Ezogabine—Dizziness—Raloxifene—osteoporosis	0.00138	0.00171	CcSEcCtD
Ezogabine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00137	0.0017	CcSEcCtD
Ezogabine—Dizziness—Ibandronate—osteoporosis	0.00136	0.00169	CcSEcCtD
Ezogabine—Rash—Estropipate—osteoporosis	0.00136	0.00168	CcSEcCtD
Ezogabine—Dermatitis—Estropipate—osteoporosis	0.00135	0.00168	CcSEcCtD
Ezogabine—Muscle spasms—Estradiol—osteoporosis	0.00134	0.00166	CcSEcCtD
Ezogabine—Rash—Alendronate—osteoporosis	0.00134	0.00166	CcSEcCtD
Ezogabine—Dermatitis—Alendronate—osteoporosis	0.00133	0.00166	CcSEcCtD
Ezogabine—Feeling abnormal—Pamidronate—osteoporosis	0.00133	0.00165	CcSEcCtD
Ezogabine—NAT2—Biological oxidations—CYP27A1—osteoporosis	0.00133	0.023	CbGpPWpGaD
Ezogabine—Paraesthesia—Zoledronate—osteoporosis	0.00132	0.00164	CcSEcCtD
Ezogabine—Dyspnoea—Zoledronate—osteoporosis	0.00132	0.00163	CcSEcCtD
Ezogabine—Rash—Raloxifene—osteoporosis	0.00131	0.00163	CcSEcCtD
Ezogabine—Dermatitis—Raloxifene—osteoporosis	0.00131	0.00163	CcSEcCtD
Ezogabine—Somnolence—Zoledronate—osteoporosis	0.00131	0.00163	CcSEcCtD
Ezogabine—NAT2—Metapathway biotransformation—CYP27A1—osteoporosis	0.00131	0.0227	CbGpPWpGaD
Ezogabine—Tremor—Estradiol—osteoporosis	0.00131	0.00162	CcSEcCtD
Ezogabine—Rash—Ibandronate—osteoporosis	0.0013	0.00161	CcSEcCtD
Ezogabine—Dermatitis—Ibandronate—osteoporosis	0.0013	0.00161	CcSEcCtD
Ezogabine—Dyspepsia—Zoledronate—osteoporosis	0.0013	0.00161	CcSEcCtD
Ezogabine—Ill-defined disorder—Estradiol—osteoporosis	0.00129	0.0016	CcSEcCtD
Ezogabine—Nausea—Estropipate—osteoporosis	0.00128	0.00158	CcSEcCtD
Ezogabine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.00128	0.00158	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00127	0.00158	CcSEcCtD
Ezogabine—Rash—Calcitriol—osteoporosis	0.00127	0.00158	CcSEcCtD
Ezogabine—Fatigue—Zoledronate—osteoporosis	0.00127	0.00158	CcSEcCtD
Ezogabine—Dermatitis—Calcitriol—osteoporosis	0.00127	0.00158	CcSEcCtD
Ezogabine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00127	0.00157	CcSEcCtD
Ezogabine—Somnolence—Conjugated Estrogens—osteoporosis	0.00126	0.00157	CcSEcCtD
Ezogabine—Constipation—Zoledronate—osteoporosis	0.00126	0.00157	CcSEcCtD
Ezogabine—Nausea—Alendronate—osteoporosis	0.00126	0.00156	CcSEcCtD
Ezogabine—Malaise—Estradiol—osteoporosis	0.00126	0.00156	CcSEcCtD
Ezogabine—Vertigo—Estradiol—osteoporosis	0.00125	0.00155	CcSEcCtD
Ezogabine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00125	0.00155	CcSEcCtD
Ezogabine—Asthenia—Ethinyl Estradiol—osteoporosis	0.00125	0.00155	CcSEcCtD
Ezogabine—Syncope—Estradiol—osteoporosis	0.00125	0.00155	CcSEcCtD
Ezogabine—Nausea—Raloxifene—osteoporosis	0.00124	0.00154	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00123	0.00152	CcSEcCtD
Ezogabine—Fatigue—Conjugated Estrogens—osteoporosis	0.00122	0.00152	CcSEcCtD
Ezogabine—Nausea—Ibandronate—osteoporosis	0.00122	0.00152	CcSEcCtD
Ezogabine—Loss of consciousness—Estradiol—osteoporosis	0.00122	0.00152	CcSEcCtD
Ezogabine—Asthenia—Risedronate—osteoporosis	0.00122	0.00151	CcSEcCtD
Ezogabine—Feeling abnormal—Zoledronate—osteoporosis	0.00122	0.00151	CcSEcCtD
Ezogabine—Constipation—Conjugated Estrogens—osteoporosis	0.00121	0.00151	CcSEcCtD
Ezogabine—Nausea—Calcitriol—osteoporosis	0.0012	0.00149	CcSEcCtD
Ezogabine—KCNQ3—Axon guidance—CAP1—osteoporosis	0.00118	0.0205	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—CAP1—osteoporosis	0.00118	0.0205	CbGpPWpGaD
Ezogabine—Anxiety—Estradiol—osteoporosis	0.00118	0.00147	CcSEcCtD
Ezogabine—Discomfort—Estradiol—osteoporosis	0.00117	0.00145	CcSEcCtD
Ezogabine—Dry mouth—Estradiol—osteoporosis	0.00116	0.00144	CcSEcCtD
Ezogabine—Asthenia—Pamidronate—osteoporosis	0.00116	0.00144	CcSEcCtD
Ezogabine—Dizziness—Ethinyl Estradiol—osteoporosis	0.00115	0.00143	CcSEcCtD
Ezogabine—Confusional state—Estradiol—osteoporosis	0.00115	0.00142	CcSEcCtD
Ezogabine—Infection—Estradiol—osteoporosis	0.00113	0.0014	CcSEcCtD
Ezogabine—Dizziness—Risedronate—osteoporosis	0.00112	0.00139	CcSEcCtD
Ezogabine—Shock—Estradiol—osteoporosis	0.00112	0.00139	CcSEcCtD
Ezogabine—Nervous system disorder—Estradiol—osteoporosis	0.00112	0.00138	CcSEcCtD
Ezogabine—Hyperhidrosis—Estradiol—osteoporosis	0.0011	0.00136	CcSEcCtD
Ezogabine—Rash—Ethinyl Estradiol—osteoporosis	0.0011	0.00136	CcSEcCtD
Ezogabine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.0011	0.00136	CcSEcCtD
Ezogabine—Rash—Risedronate—osteoporosis	0.00107	0.00133	CcSEcCtD
Ezogabine—Dermatitis—Risedronate—osteoporosis	0.00107	0.00133	CcSEcCtD
Ezogabine—Dizziness—Pamidronate—osteoporosis	0.00107	0.00133	CcSEcCtD
Ezogabine—Asthenia—Zoledronate—osteoporosis	0.00106	0.00131	CcSEcCtD
Ezogabine—Nausea—Ethinyl Estradiol—osteoporosis	0.00104	0.00128	CcSEcCtD
Ezogabine—Paraesthesia—Estradiol—osteoporosis	0.00102	0.00127	CcSEcCtD
Ezogabine—Asthenia—Conjugated Estrogens—osteoporosis	0.00102	0.00127	CcSEcCtD
Ezogabine—Rash—Pamidronate—osteoporosis	0.00102	0.00126	CcSEcCtD
Ezogabine—Dermatitis—Pamidronate—osteoporosis	0.00102	0.00126	CcSEcCtD
Ezogabine—Dyspnoea—Estradiol—osteoporosis	0.00101	0.00126	CcSEcCtD
Ezogabine—Somnolence—Estradiol—osteoporosis	0.00101	0.00125	CcSEcCtD
Ezogabine—Nausea—Risedronate—osteoporosis	0.00101	0.00125	CcSEcCtD
Ezogabine—Dyspepsia—Estradiol—osteoporosis	0.001	0.00124	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000982	0.00122	CcSEcCtD
Ezogabine—Fatigue—Estradiol—osteoporosis	0.00098	0.00122	CcSEcCtD
Ezogabine—Dizziness—Zoledronate—osteoporosis	0.000976	0.00121	CcSEcCtD
Ezogabine—Constipation—Estradiol—osteoporosis	0.000972	0.00121	CcSEcCtD
Ezogabine—Nausea—Pamidronate—osteoporosis	0.000959	0.00119	CcSEcCtD
Ezogabine—Dizziness—Conjugated Estrogens—osteoporosis	0.000939	0.00117	CcSEcCtD
Ezogabine—Feeling abnormal—Estradiol—osteoporosis	0.000937	0.00116	CcSEcCtD
Ezogabine—Rash—Zoledronate—osteoporosis	0.00093	0.00115	CcSEcCtD
Ezogabine—Dermatitis—Zoledronate—osteoporosis	0.000929	0.00115	CcSEcCtD
Ezogabine—Rash—Conjugated Estrogens—osteoporosis	0.000896	0.00111	CcSEcCtD
Ezogabine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000895	0.00111	CcSEcCtD
Ezogabine—Nausea—Zoledronate—osteoporosis	0.000876	0.00109	CcSEcCtD
Ezogabine—KCNQ3—Developmental Biology—CAP1—osteoporosis	0.000845	0.0147	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—CAP1—osteoporosis	0.000845	0.0147	CbGpPWpGaD
Ezogabine—Nausea—Conjugated Estrogens—osteoporosis	0.000844	0.00105	CcSEcCtD
Ezogabine—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000827	0.0143	CbGpPWpGaD
Ezogabine—CYP2A6—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000816	0.0142	CbGpPWpGaD
Ezogabine—Asthenia—Estradiol—osteoporosis	0.000816	0.00101	CcSEcCtD
Ezogabine—UGT1A4—Biological oxidations—CYP27A1—osteoporosis	0.000804	0.014	CbGpPWpGaD
Ezogabine—UGT1A4—Metapathway biotransformation—CYP27A1—osteoporosis	0.000793	0.0138	CbGpPWpGaD
Ezogabine—Dizziness—Estradiol—osteoporosis	0.000752	0.000933	CcSEcCtD
Ezogabine—KCNQ3—Axon guidance—TLN1—osteoporosis	0.000742	0.0129	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—TLN1—osteoporosis	0.000742	0.0129	CbGpPWpGaD
Ezogabine—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—GPD2—osteoporosis	0.000735	0.0128	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—ACTG1—osteoporosis	0.000732	0.0127	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—ACTG1—osteoporosis	0.000732	0.0127	CbGpPWpGaD
Ezogabine—Rash—Estradiol—osteoporosis	0.000717	0.00089	CcSEcCtD
Ezogabine—Dermatitis—Estradiol—osteoporosis	0.000716	0.000889	CcSEcCtD
Ezogabine—NAT2—Biological oxidations—CYP19A1—osteoporosis	0.000698	0.0121	CbGpPWpGaD
Ezogabine—NAT2—Metapathway biotransformation—CYP19A1—osteoporosis	0.000688	0.0119	CbGpPWpGaD
Ezogabine—Nausea—Estradiol—osteoporosis	0.000675	0.000838	CcSEcCtD
Ezogabine—KCNQ5—Neuronal System—ADCY5—osteoporosis	0.000674	0.0117	CbGpPWpGaD
Ezogabine—KCNQ4—Neuronal System—ADCY5—osteoporosis	0.000674	0.0117	CbGpPWpGaD
Ezogabine—CYP2A6—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000671	0.0116	CbGpPWpGaD
Ezogabine—UGT1A3—Biological oxidations—CYP27A1—osteoporosis	0.000669	0.0116	CbGpPWpGaD
Ezogabine—UGT1A3—Metapathway biotransformation—CYP27A1—osteoporosis	0.00066	0.0114	CbGpPWpGaD
Ezogabine—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—OXCT1—osteoporosis	0.000572	0.00992	CbGpPWpGaD
Ezogabine—UGT1A4—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	0.000541	0.00939	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—TLN1—osteoporosis	0.000529	0.00918	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—TLN1—osteoporosis	0.000529	0.00918	CbGpPWpGaD
Ezogabine—CYP2A6—Fluoropyrimidine Activity—MTHFR—osteoporosis	0.000527	0.00914	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—ACTG1—osteoporosis	0.000522	0.00906	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—ACTG1—osteoporosis	0.000522	0.00906	CbGpPWpGaD
Ezogabine—UGT1A1—Biological oxidations—CYP27A1—osteoporosis	0.000462	0.00802	CbGpPWpGaD
Ezogabine—UGT1A9—Biological oxidations—CYP27A1—osteoporosis	0.000462	0.00802	CbGpPWpGaD
Ezogabine—UGT1A1—Metapathway biotransformation—CYP27A1—osteoporosis	0.000456	0.00791	CbGpPWpGaD
Ezogabine—UGT1A9—Metapathway biotransformation—CYP27A1—osteoporosis	0.000456	0.00791	CbGpPWpGaD
Ezogabine—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	0.00045	0.00781	CbGpPWpGaD
Ezogabine—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000435	0.00754	CbGpPWpGaD
Ezogabine—CYP2A6—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000429	0.00744	CbGpPWpGaD
Ezogabine—UGT1A4—Biological oxidations—CYP19A1—osteoporosis	0.000423	0.00733	CbGpPWpGaD
Ezogabine—UGT1A4—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	0.000421	0.0073	CbGpPWpGaD
Ezogabine—NAT2—Biological oxidations—POMC—osteoporosis	0.000419	0.00727	CbGpPWpGaD
Ezogabine—UGT1A4—Metapathway biotransformation—CYP19A1—osteoporosis	0.000417	0.00723	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—WNT1—osteoporosis	0.000407	0.00706	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—WNT1—osteoporosis	0.000407	0.00706	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PKM—osteoporosis	0.000395	0.00686	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—FDPS—osteoporosis	0.000395	0.00686	CbGpPWpGaD
Ezogabine—UGT1A4—NRF2 pathway—AGER—osteoporosis	0.000395	0.00685	CbGpPWpGaD
Ezogabine—UGT1A4—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	0.000393	0.00681	CbGpPWpGaD
Ezogabine—UGT1A9—PPAR Alpha Pathway—MYC—osteoporosis	0.000382	0.00663	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—GPD2—osteoporosis	0.000375	0.0065	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PGLS—osteoporosis	0.000375	0.0065	CbGpPWpGaD
Ezogabine—KCNQ2—Neuronal System—ADCY5—osteoporosis	0.000364	0.00631	CbGpPWpGaD
Ezogabine—KCNQ3—Neuronal System—ADCY5—osteoporosis	0.000364	0.00631	CbGpPWpGaD
Ezogabine—CYP2A6—Biological oxidations—CYP27A1—osteoporosis	0.000356	0.00618	CbGpPWpGaD
Ezogabine—CYP2A6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000352	0.00611	CbGpPWpGaD
Ezogabine—UGT1A3—Biological oxidations—CYP19A1—osteoporosis	0.000351	0.00609	CbGpPWpGaD
Ezogabine—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	0.00035	0.00607	CbGpPWpGaD
Ezogabine—UGT1A3—Metapathway biotransformation—CYP19A1—osteoporosis	0.000346	0.00601	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ATIC—osteoporosis	0.000343	0.00595	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PNP—osteoporosis	0.000343	0.00595	CbGpPWpGaD
Ezogabine—UGT1A3—NRF2 pathway—AGER—osteoporosis	0.000328	0.0057	CbGpPWpGaD
Ezogabine—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	0.000327	0.00566	CbGpPWpGaD
Ezogabine—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	0.000311	0.00539	CbGpPWpGaD
Ezogabine—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	0.000311	0.00539	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000309	0.00536	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000293	0.00508	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—OXCT1—osteoporosis	0.000291	0.00506	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—CA2—osteoporosis	0.000291	0.00506	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—MGLL—osteoporosis	0.000284	0.00493	CbGpPWpGaD
Ezogabine—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000261	0.00453	CbGpPWpGaD
Ezogabine—UGT1A4—Biological oxidations—POMC—osteoporosis	0.000254	0.00441	CbGpPWpGaD
Ezogabine—UGT1A9—Biological oxidations—CYP19A1—osteoporosis	0.000243	0.00421	CbGpPWpGaD
Ezogabine—UGT1A1—Biological oxidations—CYP19A1—osteoporosis	0.000243	0.00421	CbGpPWpGaD
Ezogabine—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	0.000242	0.00419	CbGpPWpGaD
Ezogabine—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	0.000242	0.00419	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—IDH2—osteoporosis	0.000242	0.00419	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PKM—osteoporosis	0.00024	0.00416	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—FDPS—osteoporosis	0.00024	0.00416	CbGpPWpGaD
Ezogabine—UGT1A1—Metapathway biotransformation—CYP19A1—osteoporosis	0.000239	0.00415	CbGpPWpGaD
Ezogabine—UGT1A9—Metapathway biotransformation—CYP19A1—osteoporosis	0.000239	0.00415	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—IL6R—osteoporosis	0.000232	0.00402	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—IL6R—osteoporosis	0.000232	0.00402	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000228	0.00395	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GPD2—osteoporosis	0.000227	0.00394	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PGLS—osteoporosis	0.000227	0.00394	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—CYP27A1—osteoporosis	0.000227	0.00394	CbGpPWpGaD
Ezogabine—UGT1A1—NRF2 pathway—AGER—osteoporosis	0.000227	0.00394	CbGpPWpGaD
Ezogabine—UGT1A9—NRF2 pathway—AGER—osteoporosis	0.000227	0.00394	CbGpPWpGaD
Ezogabine—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	0.000226	0.00391	CbGpPWpGaD
Ezogabine—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	0.000226	0.00391	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000222	0.00385	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ACP5—osteoporosis	0.000221	0.00383	CbGpPWpGaD
Ezogabine—CYP2A6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000212	0.00367	CbGpPWpGaD
Ezogabine—UGT1A3—Biological oxidations—POMC—osteoporosis	0.000211	0.00366	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PNP—osteoporosis	0.000208	0.0036	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ATIC—osteoporosis	0.000208	0.0036	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—TPI1—osteoporosis	0.000205	0.00356	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PKM—osteoporosis	0.000199	0.00345	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—FDPS—osteoporosis	0.000199	0.00345	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—LEP—osteoporosis	0.000197	0.00342	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—LEP—osteoporosis	0.000197	0.00342	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—P4HB—osteoporosis	0.000193	0.00335	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—GAPDH—osteoporosis	0.00019	0.00329	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PGLS—osteoporosis	0.000189	0.00327	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GPD2—osteoporosis	0.000189	0.00327	CbGpPWpGaD
Ezogabine—CYP2A6—Biological oxidations—CYP19A1—osteoporosis	0.000187	0.00325	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—RAP1A—osteoporosis	0.000185	0.0032	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000177	0.00308	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CA2—osteoporosis	0.000177	0.00306	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—OXCT1—osteoporosis	0.000177	0.00306	CbGpPWpGaD
Ezogabine—CYP2A6—NRF2 pathway—AGER—osteoporosis	0.000175	0.00303	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PNP—osteoporosis	0.000173	0.00299	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ATIC—osteoporosis	0.000173	0.00299	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—MGLL—osteoporosis	0.000172	0.00299	CbGpPWpGaD
Ezogabine—UGT1A4—NRF2 pathway—TGFB1—osteoporosis	0.000167	0.0029	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—IL6R—osteoporosis	0.000165	0.00287	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—IL6R—osteoporosis	0.000165	0.00287	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000151	0.00262	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ENO1—osteoporosis	0.000149	0.00259	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PSMA5—osteoporosis	0.000147	0.00255	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PSMA2—osteoporosis	0.000147	0.00255	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CA2—osteoporosis	0.000147	0.00255	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—OXCT1—osteoporosis	0.000147	0.00255	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—IDH2—osteoporosis	0.000146	0.00254	CbGpPWpGaD
Ezogabine—UGT1A1—Biological oxidations—POMC—osteoporosis	0.000146	0.00253	CbGpPWpGaD
Ezogabine—UGT1A9—Biological oxidations—POMC—osteoporosis	0.000146	0.00253	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—MGLL—osteoporosis	0.000143	0.00248	CbGpPWpGaD
Ezogabine—UGT1A3—NRF2 pathway—TGFB1—osteoporosis	0.000139	0.00241	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—FDPS—osteoporosis	0.000138	0.00239	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PKM—osteoporosis	0.000138	0.00239	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CYP27A1—osteoporosis	0.000138	0.00239	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PKM—osteoporosis	0.000138	0.00239	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—FDPS—osteoporosis	0.000138	0.00239	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ACP5—osteoporosis	0.000134	0.00232	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GPD2—osteoporosis	0.00013	0.00226	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PGLS—osteoporosis	0.00013	0.00226	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GPD2—osteoporosis	0.00013	0.00226	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PGLS—osteoporosis	0.00013	0.00226	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—TPI1—osteoporosis	0.000124	0.00216	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—IDH2—osteoporosis	0.000122	0.00211	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—CYP19A1—osteoporosis	0.000119	0.00207	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ATIC—osteoporosis	0.000119	0.00207	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ATIC—osteoporosis	0.000119	0.00207	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PNP—osteoporosis	0.000119	0.00207	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PNP—osteoporosis	0.000119	0.00207	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—P4HB—osteoporosis	0.000117	0.00203	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GAPDH—osteoporosis	0.000115	0.00199	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CYP27A1—osteoporosis	0.000114	0.00198	CbGpPWpGaD
Ezogabine—CYP2A6—Biological oxidations—POMC—osteoporosis	0.000112	0.00195	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—RAP1A—osteoporosis	0.000112	0.00194	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ACP5—osteoporosis	0.000111	0.00193	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—FDPS—osteoporosis	0.000106	0.00184	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PKM—osteoporosis	0.000106	0.00184	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—TPI1—osteoporosis	0.000103	0.00179	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—IL6—osteoporosis	0.000103	0.00179	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—IL6—osteoporosis	0.000103	0.00179	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—OXCT1—osteoporosis	0.000101	0.00176	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—OXCT1—osteoporosis	0.000101	0.00176	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CA2—osteoporosis	0.000101	0.00176	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CA2—osteoporosis	0.000101	0.00176	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PGLS—osteoporosis	0.000101	0.00174	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GPD2—osteoporosis	0.000101	0.00174	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—MGLL—osteoporosis	9.88e-05	0.00171	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—MGLL—osteoporosis	9.88e-05	0.00171	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—TGFB1—osteoporosis	9.77e-05	0.0017	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—TGFB1—osteoporosis	9.77e-05	0.0017	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ADCY5—osteoporosis	9.75e-05	0.00169	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—P4HB—osteoporosis	9.72e-05	0.00169	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—GPX1—osteoporosis	9.71e-05	0.00168	CbGpPWpGaD
Ezogabine—UGT1A1—NRF2 pathway—TGFB1—osteoporosis	9.59e-05	0.00166	CbGpPWpGaD
Ezogabine—UGT1A9—NRF2 pathway—TGFB1—osteoporosis	9.59e-05	0.00166	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GAPDH—osteoporosis	9.54e-05	0.00166	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	9.32e-05	0.00162	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—RAP1A—osteoporosis	9.3e-05	0.00161	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ATIC—osteoporosis	9.2e-05	0.0016	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PNP—osteoporosis	9.2e-05	0.0016	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—TNF—osteoporosis	9.13e-05	0.00158	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—TNF—osteoporosis	9.13e-05	0.00158	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ENO1—osteoporosis	9.04e-05	0.00157	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—MTHFR—osteoporosis	8.96e-05	0.00155	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PSMA2—osteoporosis	8.91e-05	0.00155	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PSMA5—osteoporosis	8.91e-05	0.00155	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—IDH2—osteoporosis	8.4e-05	0.00146	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—IDH2—osteoporosis	8.4e-05	0.00146	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP27A1—osteoporosis	7.9e-05	0.00137	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP27A1—osteoporosis	7.9e-05	0.00137	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—OXCT1—osteoporosis	7.82e-05	0.00136	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CA2—osteoporosis	7.82e-05	0.00136	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ACP5—osteoporosis	7.69e-05	0.00133	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ACP5—osteoporosis	7.69e-05	0.00133	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—MGLL—osteoporosis	7.62e-05	0.00132	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	7.59e-05	0.00132	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ENO1—osteoporosis	7.51e-05	0.0013	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PSMA2—osteoporosis	7.4e-05	0.00128	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PSMA5—osteoporosis	7.4e-05	0.00128	CbGpPWpGaD
Ezogabine—CYP2A6—NRF2 pathway—TGFB1—osteoporosis	7.39e-05	0.00128	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—IL6—osteoporosis	7.36e-05	0.00128	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—IL6—osteoporosis	7.36e-05	0.00128	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CYP19A1—osteoporosis	7.23e-05	0.00125	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—POMC—osteoporosis	7.17e-05	0.00124	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—TPI1—osteoporosis	7.15e-05	0.00124	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—TPI1—osteoporosis	7.15e-05	0.00124	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—P4HB—osteoporosis	6.72e-05	0.00117	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—P4HB—osteoporosis	6.72e-05	0.00117	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GAPDH—osteoporosis	6.59e-05	0.00114	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GAPDH—osteoporosis	6.59e-05	0.00114	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—IDH2—osteoporosis	6.48e-05	0.00112	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—RAP1A—osteoporosis	6.42e-05	0.00111	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—RAP1A—osteoporosis	6.42e-05	0.00111	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CYP27A1—osteoporosis	6.09e-05	0.00106	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CYP19A1—osteoporosis	6.01e-05	0.00104	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ACP5—osteoporosis	5.93e-05	0.00103	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ADCY5—osteoporosis	5.91e-05	0.00102	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GPX1—osteoporosis	5.88e-05	0.00102	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	5.6e-05	0.000972	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—TPI1—osteoporosis	5.51e-05	0.000956	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—MTHFR—osteoporosis	5.43e-05	0.000942	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ENO1—osteoporosis	5.19e-05	0.000901	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ENO1—osteoporosis	5.19e-05	0.000901	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—P4HB—osteoporosis	5.18e-05	0.000898	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PSMA2—osteoporosis	5.12e-05	0.000888	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PSMA5—osteoporosis	5.12e-05	0.000888	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PSMA2—osteoporosis	5.12e-05	0.000888	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PSMA5—osteoporosis	5.12e-05	0.000888	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GAPDH—osteoporosis	5.08e-05	0.000882	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—RAP1A—osteoporosis	4.95e-05	0.000859	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ADCY5—osteoporosis	4.91e-05	0.000852	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GPX1—osteoporosis	4.89e-05	0.000849	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—MTHFR—osteoporosis	4.51e-05	0.000783	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—POMC—osteoporosis	4.34e-05	0.000753	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP19A1—osteoporosis	4.15e-05	0.00072	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP19A1—osteoporosis	4.15e-05	0.00072	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ENO1—osteoporosis	4e-05	0.000694	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PSMA2—osteoporosis	3.94e-05	0.000684	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PSMA5—osteoporosis	3.94e-05	0.000684	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—POMC—osteoporosis	3.61e-05	0.000626	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ADCY5—osteoporosis	3.39e-05	0.000588	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ADCY5—osteoporosis	3.39e-05	0.000588	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GPX1—osteoporosis	3.38e-05	0.000586	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GPX1—osteoporosis	3.38e-05	0.000586	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CYP19A1—osteoporosis	3.2e-05	0.000555	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—MTHFR—osteoporosis	3.12e-05	0.000541	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—MTHFR—osteoporosis	3.12e-05	0.000541	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ADCY5—osteoporosis	2.61e-05	0.000454	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GPX1—osteoporosis	2.61e-05	0.000452	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—POMC—osteoporosis	2.49e-05	0.000433	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—POMC—osteoporosis	2.49e-05	0.000433	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—MTHFR—osteoporosis	2.4e-05	0.000417	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—POMC—osteoporosis	1.92e-05	0.000334	CbGpPWpGaD
